A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects

A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients

NCT00046332 ·Status: COMPLETED ·Phase: PHASE2

A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects

NCT00000792 ·Status: COMPLETED ·Phase: PHASE1

A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease

NCT00002033 ·Status: COMPLETED ·Phase: NA

A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.

NCT00002111 ·Status: COMPLETED ·Phase: PHASE1

A Study of an Oral Entry Inhibitor, SP01A, in Treatment-Experienced HIV-Infected Patients

NCT00113412 ·Status: UNKNOWN ·Phase: PHASE2

Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)

NCT06045507 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study Of PF-00232798 In HIV Positive Patients

NCT00495677 ·Status: COMPLETED ·Phase: PHASE2

The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients

NCT00002311 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Effectiveness of SPC3 in HIV-1 Infected Patients

NCT00002363 ·Status: COMPLETED ·Phase: PHASE1

Phase Ib/IIa Clinical Study of ACC017 Tablets

NCT06719310 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine

NCT00002035 ·Status: COMPLETED ·Phase: NA

Combination Therapy With 3BNC117 and 10-1074 in HIV-Infected Individuals

NCT03571204 ·Status: TERMINATED ·Phase: PHASE1

A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons

NCT00000743 ·Status: COMPLETED ·Phase: PHASE1

First-in-human Study of 10-1074-LS Alone and in Combination With 3BNC117-LS

NCT03554408 ·Status: COMPLETED ·Phase: PHASE1

A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.

NCT00002097 ·Status: COMPLETED ·Phase: PHASE1

Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex

NCT00000692 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals

NCT00002087 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89

NCT00002141 ·Status: COMPLETED ·Phase: PHASE1

Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels

NCT00143624 ·Status: COMPLETED ·Phase: NA

Safety and Tolerability of PRO 140 in HIV Uninfected Male Volunteers

NCT00110591 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Effectiveness of 524W91

NCT00002335 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human Immunodeficiency Virus-1 (HIV-1) Infected Patients.

NCT00000391 ·Status: COMPLETED ·Phase: PHASE1

Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors

NCT00007449 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy

NCT05612178 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol

NCT03517358 ·Status: COMPLETED ·Phase: PHASE3